These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 33637951)
1. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. Aghili SMM; Ebrahimpur M; Arjmand B; Shadman Z; Pejman Sani M; Qorbani M; Larijani B; Payab M Int J Obes (Lond); 2021 May; 45(5):998-1016. PubMed ID: 33637951 [TBL] [Abstract][Full Text] [Related]
2. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265 [TBL] [Abstract][Full Text] [Related]
4. Effect of the COVID-19 pandemic on obesity and it is risk factors: a systematic review. Nour TY; Altintaş KH BMC Public Health; 2023 May; 23(1):1018. PubMed ID: 37254139 [TBL] [Abstract][Full Text] [Related]
5. The Weight of Obesity in Immunity from Influenza to COVID-19. Andrade FB; Gualberto A; Rezende C; Percegoni N; Gameiro J; Hottz ED Front Cell Infect Microbiol; 2021; 11():638852. PubMed ID: 33816341 [TBL] [Abstract][Full Text] [Related]
6. Obesity as an adipose tissue dysfunction disease and a risk factor for infections - Covid-19 as a case study. Landecho MF; Marin-Oto M; Recalde-Zamacona B; Bilbao I; Frühbeck G Eur J Intern Med; 2021 Sep; 91():3-9. PubMed ID: 33858724 [TBL] [Abstract][Full Text] [Related]
7. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology. Suárez-Reyes A; Villegas-Valverde CA MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614 [TBL] [Abstract][Full Text] [Related]
8. An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19. Argano C; Mallaci Bocchio R; Lo Monaco M; Scibetta S; Natoli G; Cavezzi A; Troiani E; Corrao S Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270015 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
10. Cytokines Involved in COVID-19 Patients with Diabetes: A Systematic Review. George TP; Joy SS; Rafiullah M; Siddiqui K Curr Diabetes Rev; 2023; 19(3):e180122200321. PubMed ID: 35040414 [TBL] [Abstract][Full Text] [Related]
11. Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis. Cai Z; Yang Y; Zhang J BMC Public Health; 2021 Aug; 21(1):1505. PubMed ID: 34348687 [TBL] [Abstract][Full Text] [Related]
12. Obesity and clinical severity in patients with COVID-19: a scoping review protocol. Costa ML; Souza CAS; Silva ACC; Santos DFC; Nonato EF; Santana FB; Dos Santos Dias G; Barreto JT; Costa LS; Costa MCB; das Neves Ferreira T; Santana JS; Mendes-Netto RS; do Nascimento TVSB; Nunes MAP; de Souza MFC Syst Rev; 2021 Feb; 10(1):51. PubMed ID: 33550984 [TBL] [Abstract][Full Text] [Related]
13. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. Dessie ZG; Zewotir T BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980 [TBL] [Abstract][Full Text] [Related]
14. Excess body weight is an independent risk factor for severe forms of COVID-19. Pietri L; Giorgi R; Bégu A; Lojou M; Koubi M; Cauchois R; Grangeot R; Dubois N; Kaplanski G; Valéro R; Béliard S Metabolism; 2021 Apr; 117():154703. PubMed ID: 33421506 [TBL] [Abstract][Full Text] [Related]
15. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature. Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925 [TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review. Ferguson M; Vel J; Phan V; Ali R; Mabe L; Cherner A; Doan T; Manakatt B; Jose M; Powell AR; McKinney K; Serag H; Sallam HS Metab Syndr Relat Disord; 2023 May; 21(4):177-187. PubMed ID: 37130311 [TBL] [Abstract][Full Text] [Related]
17. Diabetes in the COVID-19 pandemic era. Bonansea TCP; Santos LPD; Zintl K; Souza ACDS Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303 [TBL] [Abstract][Full Text] [Related]
19. Obesity and COVID-19 in children and adolescents: a double pandemic. Brambilla I; Delle Cave F; Guarracino C; De Filippo M; Votto M; Licari A; Pistone C; Tondina E Acta Biomed; 2022 Jun; 93(S3):e2022195. PubMed ID: 35666114 [TBL] [Abstract][Full Text] [Related]
20. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities. Yan T; Xiao R; Wang N; Shang R; Lin G Theranostics; 2021; 11(17):8234-8253. PubMed ID: 34373739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]